Free Trial
→ Urgent Buy Alert: My Top Three Quantum Computing Stocks (From Brownstone Research) (Ad)tc pixel

Short Interest in Fresenius SE & Co. (OTCMKTS:FSNUY) Increases By 113.3%

Written by MarketBeat
October 4, 2025
Fresenius SE & Co. logo with Medical background

Key Points

  • Short interest in Fresenius SE & Co. saw a remarkable increase of 113.3% in September, rising from 23,300 shares to 49,700 shares as of September 15th.
  • The company reported earnings of $0.24 per share for the previous quarter, exceeding analysts' expectations of $0.22 and generating $6.48 billion in revenue.
  • Wall Street analysts currently have an average rating of "Buy" for Fresenius SE & Co., with one analyst rating it as a Strong Buy and two as Buy.
  • Five stocks we like better than Fresenius SE & Co..

Fresenius SE & Co. (OTCMKTS:FSNUY - Get Free Report) saw a significant growth in short interest in the month of September. As of September 15th, there was short interest totaling 49,700 shares, a growth of 113.3% from the August 31st total of 23,300 shares. Based on an average daily trading volume, of 52,500 shares, the days-to-cover ratio is presently 0.9 days. Based on an average daily trading volume, of 52,500 shares, the days-to-cover ratio is presently 0.9 days.

Fresenius SE & Co. Price Performance

OTCMKTS:FSNUY traded up $0.09 during trading hours on Friday, hitting $13.91. 56,354 shares of the stock traded hands, compared to its average volume of 39,560. The company has a quick ratio of 1.00, a current ratio of 1.31 and a debt-to-equity ratio of 0.49. Fresenius SE & Co. has a 1 year low of $8.48 and a 1 year high of $14.24. The company has a market cap of $31.08 billion, a price-to-earnings ratio of 26.25 and a beta of 0.83. The stock has a 50 day moving average price of $13.43 and a 200 day moving average price of $12.37.

Fresenius SE & Co. (OTCMKTS:FSNUY - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The company reported $0.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.22 by $0.02. The firm had revenue of $6.48 billion for the quarter, compared to analysts' expectations of $5.83 billion. Fresenius SE & Co. had a net margin of 5.09% and a return on equity of 9.33%. Sell-side analysts forecast that Fresenius SE & Co. will post 0.79 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Morgan Stanley restated an "overweight" rating on shares of Fresenius SE & Co. in a research report on Wednesday, August 13th. One equities research analyst has rated the stock with a Strong Buy rating and two have assigned a Buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of "Buy".

Check Out Our Latest Analysis on Fresenius SE & Co.

About Fresenius SE & Co.

(Get Free Report)

Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Fresenius SE & Co. Right Now?

Before you consider Fresenius SE & Co., you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius SE & Co. wasn't on the list.

While Fresenius SE & Co. currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover
7 Stocks to Ride The A.I. Megaboom


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.